CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
This dataset contains the raw data obtained for the DARTS/proteomics and the metabolomics analyses performed to identify the putative target of CMS121, an Alzheimer's disease drug candidate. We refer to the published manuscript for more detailed information: https://doi.org/10.1016/j.redox.2020.101648
创建时间：
2020-07-22
